Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Patients feeling severely affected by multiple sclerosis: How do patients want to communicate about end-of-life issues?
Cerebrospinal fluid IL-1β correlates with cortical pathology load in multiple sclerosis at clinical onset.
Dalfampridine Effects Beyond Walking Speed in Multiple Sclerosis.
An Adult Case of Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Multiphasic Acute Disseminated Encephalomyelitis at 33-year Intervals.
Efficacy of idebenone for respiratory failure in a patient with Leigh syndrome: a long-term follow-up study.
Tocilizumab, MS, and NMOSD.
How Natalizumab Binds and Antagonizes α4 Integrins.
Cost-effectiveness of natalizumab vs fingolimod for the treatment of relapsing-remitting multiple sclerosis: analyses in Sweden.
Changed histone acetylation patterns in normal-appearing white matter and early multiple sclerosis lesions.
Chaperone activity of α B-crystallin is responsible for its incorrect assignment as an autoantigen in multiple sclerosis.
Information on natalizumab (marketed as Tysabri)
Efficacy of fingolimod in patients with highly active relapsing-remitting multiple sclerosis.
Lipoatrophy in patients with multiple sclerosis on glatiramer acetate.
CD46: The 'multitasker' of complement proteins.
A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Treatment of facial myokymia in multiple sclerosis with botulinum toxin.
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial.
Product Insert, Amiloride HCl Tablets
Interferon beta 1a-induced severe autoimmune hepatitis in patients with multiple sclerosis: report of two cases and review of the literature.
A questionnaire for multinational case-control studies of environmental risk factors in multiple sclerosis (EnvIMS-Q).
Repeated treatment with high dose cyclophosphamide for severe autoimmune diseases.
Motor impairments at presentation of clinically isolated syndrome suggestive of multiple sclerosis: Characterization of different disease subtypes.
Pathogenesis of multiple sclerosis via environmental and genetic dysregulation of N-glycosylation.
Adherence to interferon β-1a therapy using an electronic self-injector in multiple sclerosis: a multicentre, single-arm, observational, phase IV study.
Innovation at RUSH

Pages